Project Number 1U01AG047222-01 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for ALLOPREGNANOLONE A REGENERATIVE THERAPY FOR ALZHEIMER'S: FDA-REQUIRED TOXICOLOG Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF SOUTHERN CALIFORNIA Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-12-015: Alzheimer's Disease Drug Development Program (U01) FY Overall Cost $721,277 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
